Anita M Hennige
7PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 17, 2025
Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist.Carel W le Roux, Oren Steen, Kathryn J Lucas
|Nov 25, 2024
Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo-controlled, dose-finding, phase 2 trial.Carel W le Roux, Oren Steen, Kathryn J Lucas
|Oct 07, 2024
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low-dose liraglutide in otherwise healthy men with overweight or obesity.Nadine Beetz, Brigitte Kalsch, Thomas Forst
|Feb 13, 2024
Correction to: Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.Matthias Blüher, Julio Rosenstock, Josef Hoefler
|Dec 14, 2023
Dose-response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial.Matthias Blüher, Julio Rosenstock, Josef Hoefler
Pageof 2
Frequent Collaborators
2 joint publications
Matthias Blüher
2 joint publications
Julio Rosenstock
2 joint publications
Carel W le Roux
2 joint publications
Elif I Ekinci
1 joint publications
Nadine Beetz
1 joint publications
Thomas Forst
1 joint publications
Bernhard Schmid
1 joint publications
Sandra González Maldonado
1 joint publications
Jorge Arrubla Martinez
1 joint publications
Corinna Schoelch